三甲氧苄嗪是一种新型代谢性抗心肌缺血药物。本文报告作者关于三甲氧苄嗪对老年缺血性心肌病(ICMP)患者左心室功能和体力负荷耐量的作用进行研究的结果。对象与方法共选择82例ICMP患者为研究对象。男68例、女14例;平均年龄65±5.2岁。既往均患过心肌梗死。为了便于治疗将全部 Trimethoprim is a new type of metabolic anti-ischemic drug. This article reports the authors’ results regarding the effect of trimebutine on left ventricular function and physical endurance in patients with senile ischemic cardiomyopathy (ICMP). Subjects and Methods A total of 82 ICMP patients were selected as the research object. There were 68 males and 14 females with an average age of 65 ± 5.2 years. I have had previous myocardial infarction. For ease of treatment will be all